---
title: "New Stock IPO | News: Laifual oversubscribed 4,576 times"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290804106.md"
description: "Today, four new stocks closed for public offering, among which LAIFUAL recorded an oversubscription of 4,576 times, attracting 183,000 participants; XUNLONG SCITECH was oversubscribed 2,136 times, TH MEDICAL-B was oversubscribed 1,792 times, and JIANGXI BIO was oversubscribed 477 times"
datetime: "2026-06-25T09:10:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290804106.md)
  - [en](https://longbridge.com/en/news/290804106.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290804106.md)
---

# New Stock IPO | News: Laifual oversubscribed 4,576 times

Today, 4 new stocks are closing their public offerings. According to market news, the core component provider for precision transmission in robotics, LAIFUAL ( 03952), has initially recorded an oversubscription of 4,576 times, attracting 183,000 applicants.

Reports indicate that the public offering portion of caviar company XUNLONG SCITECH ( 06715) has initially recorded an oversubscription of 2,136 times, with 180,000 applicants.

The public offering portion of TH MEDICAL ( 02697), a mainland manufacturer of percutaneous surgical robots, has initially recorded an oversubscription of 1,792 times; a total of 128,000 people applied.

Jiangxi Bio ( 06915), the largest provider and exporter of human tetanus antitoxin ("human TAT") in China, has recorded an oversubscription of 477 times in its public offering, with 78,000 applicants

### Related Stocks

- [06715.HK](https://longbridge.com/en/quote/06715.HK.md)
- [02697.HK](https://longbridge.com/en/quote/02697.HK.md)
- [06915.HK](https://longbridge.com/en/quote/06915.HK.md)
- [03952.HK](https://longbridge.com/en/quote/03952.HK.md)

## Related News & Research

- [ZhenHealth's HK IPO tests global appetite for pre-revenue medical assets](https://longbridge.com/en/news/290939539.md)
- [Hong Kong's 'Hard Tech' Boom Is a Chaotic Mix of Real AI Hardware and Desperate Corporate Pivots](https://longbridge.com/en/news/290939355.md)
- [Jiangxi Rimag says trustee buys 7,501,000 shares on-market for share award scheme](https://longbridge.com/en/news/290552766.md)
- [20:00 ETLOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use](https://longbridge.com/en/news/290362832.md)
- [ZAWYA: Abu Dhabi Biobank and BioTwin announce strategic partnership to expand human virtual twin technology in the UAE](https://longbridge.com/en/news/290948225.md)